Beam Therapeutics, launched in 2018, is pioneering the use of CRISPR base editing to develop a broad portfolio of advanced genetic medicines. Our groundbreaking base editing technology allows us to make permanent, specific edits to single bases in DNA and RNA, without cutting the strands. Base editor therapeutics represent a new class of “precision genetic medicines,” combining precision targeting of the genome with precision control of editing outcomes. Our dream is to provide life-long cures for patients suffering from serious diseases. The Beam Team Is: • A community of fearless innovators • Rigorous and honest in our research • Listening with open minds • Committed to each other
View Top Employees from Beam Therapeutics| Website | http://beamtx.com |
| Ticker | BEAM |
| Revenue | $18000 |
| Funding | $806.5 million |
| Employees | 632 (632 on RocketReach) |
| Founded | 2017 |
| Address | 238 Main St, Cambridge, Massachusetts 02142, US |
| Phone | (857) 327-8775 |
| Technologies |
JavaScript,
HTML,
PHP
+77 more
(view full list)
|
| Category | Biotechnology Research, Business Services General, Genetics, Business Services, Biotechnology, Health Care, Medical, Therapeutics |
| SIC | 873, 87 |
| NAICS | 54, 541711, 54171, 541, 5417 |
Looking for a particular Beam Therapeutics employee's phone or email?
Beam Therapeutics Questions
The Beam Therapeutics annual revenue was $18000 in 2023.
Giuseppe Ciaramella is the President of Beam Therapeutics.
632 people are employed at Beam Therapeutics.
Beam Therapeutics is based in Cambridge, Massachusetts.
The NAICS codes for Beam Therapeutics are [54, 541711, 54171, 541, 5417].
The SIC codes for Beam Therapeutics are [873, 87].
Top Beam Therapeutics Employees
-
35+
-
11
-
11
-
15
-
25+
-
25+
-
21
-
32
-
23
Related Companies
